Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hellerstedt, B.
Right arrow Articles by Ahmed, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hellerstedt, B.
Right arrow Articles by Ahmed, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 14:1792, 2003
© 2003 European Society for Medical Oncology

Letters to the Editor

Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment

B. Hellerstedt and A. Ahmed*

Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA

*E-mail: aahmed@umich.edu

The first 10% of the full text of this article appears below.

We report a case of significant delayed cutaneous reaction and possible serum sickness associated with rituximab treatment.

The patient is a 23-year-old female with a long-standing diagnosis of lupus, on chronic steroids. Her recent pregnancy was complicated by autoimmune hemolytic anemia, which required high doses of steroids and periodic blood transfusions. During her pregnancy, she . . . [Full Text of this Article]

Acknowledgements


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?